AdvisorShares Investments LLC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 111 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
AdvisorShares Investments LLC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q2 2021$877,000
-9.4%
479,453
-2.4%
0.12%
-0.8%
Q1 2021$968,000
+184.7%
491,126
+80.6%
0.12%
+53.2%
Q4 2020$340,000
-32.5%
271,873
-2.8%
0.08%
+229.2%
Q3 2020$504,000
-68.4%
279,671
+47.3%
0.02%
-96.5%
Q2 2020$1,593,000
-3.7%
189,814
-39.9%
0.68%
-52.9%
Q1 2020$1,655,000
-20.4%
315,889
-17.0%
1.44%
+11.1%
Q4 2019$2,079,000380,7501.29%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q1 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,738,925$23,555,00031.22%
Perceptive Advisors 1,232,500$7,764,0000.39%
IFP Advisors, Inc 1,001,025$6,306,0000.27%
WOODSTOCK CORP 55,489$350,0000.07%
Virtus ETF Advisers LLC 50,795$320,0000.05%
Dynamic Technology Lab Private Ltd 31,431$198,0000.04%
Evanson Asset Management, LLC 20,660$130,0000.03%
Artal Group S.A. 250,000$1,575,0000.03%
GSA CAPITAL PARTNERS LLP 58,800$370,0000.02%
Raymond James Financial Services Advisors, Inc. 426,280$2,686,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders